Tumor of hematopoietic and lymphoid tissues Advocacy Hub | UniteRare

At a Glance

Live from database

🔬

62Recruiting trials

🩺

20Specialists

Regulatory Watchboard

10 events

Jul 2026Assessing DCog Short for Neurotoxicity in CAR-T

Beth Israel Deaconess Medical Center — NA

TrialNOT YET RECRUITING

Jun 2026Dose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis in Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation

Hannah Choe, MD — PHASE2

TrialRECRUITING

Apr 2026Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies

National Cancer Institute (NCI) — PHASE1

TrialRECRUITING

Mar 2026BY002 IIT Study in R/R Acute Leukemia

The First Affiliated Hospital of Soochow University — PHASE1

TrialRECRUITING

Mar 2026CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and Lymphoma

St. Jude Children's Research Hospital — PHASE1

TrialRECRUITING

Mar 2026Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of Lymphoma

ModeX Therapeutics, An OPKO Health Company — PHASE1, PHASE2

TrialRECRUITING

Feb 2026Safety and Efficacy of GYA01 (CART84) in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) and Acute Lymphoblastic T Leukemia Patients (T-ALL).

Gyala Therapeutics — PHASE1, PHASE2

TrialRECRUITING

Jan 2026This is a Phase I/II Interventional, Open-label Treatment Study Designed to Evaluate the Safety and Efficacy of Anti CD 19/22 CAR- T Cells Immunotherapy for Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia/Lymphoma.

Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology — PHASE1, PHASE2

TrialNOT YET RECRUITING

Dec 2025Early Versus Late Stopping of Antibiotics in Adults With High-risk Hematological Malignancies/Receiving Cellular Therapies and Fever

Peter MacCallum Cancer Centre, Australia — NA

TrialRECRUITING

Nov 2025What is the Impact of TKI on Thyroid Function in CML Patients?

Assiut University

TrialNOT YET RECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

Total programs

No financial assistance programs currently listed for Tumor of hematopoietic and lymphoid tissues.
Check the disease page for updates →

Clinical Trial Landscape

62 active trials

1Phase 3

9Phase 2

15Phase 1

11N/A

16Unknown

8PHASE1, PHASE2

2EARLY_PHASE1

62Total recruiting

Search clinical trials for Tumor of hematopoietic and lymphoid tissues →

Recent News & Research

No recent news articles indexed yet for Tumor of hematopoietic and lymphoid tissues.
Search PubMed for Tumor of hematopoietic and lymphoid tissues →

Browse all Tumor of hematopoietic and lymphoid tissues news →

Specialist Network

Top 6 by expertise

David Maloney

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

Score 2111 trials

Marie Bleakley, MD

Fred Hutch/University of Washington Cancer Consortium

📍 SEATTLE, WA

Score 124 trials

Thomas C. Shea, MD

UNC Lineberger Comprehensive Cancer Center

Score 94 trials

Ryotaro Nakamura

City of Hope Medical Center

📍 Duarte, California

Score 96 trials

Thomas G. Martin, MD

University of California, San Francisco

Score 94 trials

Hussein A Tawbi, MD

University of Pittsburgh Cancer Institute (UPCI)

📍 HOUSTON, TX

Score 92 trials

View all Tumor of hematopoietic and lymphoid tissues specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰